AAAAAA
Results: 26-50/50
Authors:
Makkonen, TA
Minn, H
Jekunen, A
Vilja, P
Tuominen, J
Joensuu, H
Citation: Ta. Makkonen et al., Granulocyte macrophage-colony stimulating factor (GM-CSF) and sucralfate in prevention of radiation-induced mucositis: A prospective randomized study, INT J RAD O, 46(3), 2000, pp. 525-534
Authors:
Joensuu, H
Holli, K
Oksanen, H
Valavaara, R
Citation: H. Joensuu et al., Serum lipid levels during and after adjuvant toremifene or tamoxifen therapy for breast cancer, BREAST CANC, 63(3), 2000, pp. 225-234
Authors:
Hemminki, A
Mecklin, JP
Jarvinen, H
Aaltonen, LA
Joensuu, H
Citation: A. Hemminki et al., Microsatellite instability is a favorable prognostic indicator in patientswith colorectal cancer receiving chemotherapy, GASTROENTY, 119(4), 2000, pp. 921-928
Authors:
Erselcan, T
Kairemo, KJA
Wiklund, TA
Hernberg, M
Blomqvist, CP
Tenhunen, M
Bergh, J
Joensuu, H
Citation: T. Erselcan et al., Subclinical cardiotoxicity following adjuvant dose-escalated FEC, high-dose chemotherapy, or CMF in breast cancer, BR J CANC, 82(4), 2000, pp. 777-781
Authors:
Salven, P
Orpana, A
Teerenhovi, L
Joensuu, H
Citation: P. Salven et al., Simultaneous elevation in the serum concentrations of the angiogenic growth factors VEGF and bFGF is an independent predictor of poor prognosis in non-Hodgkin lymphoma: a single-institution study of 200 patients, BLOOD, 96(12), 2000, pp. 3712-3718
Authors:
Bondestam, J
Salven, P
Jaaskela-Saari, H
Ikonen, T
Lepantalo, M
Mattila, S
Joensuu, H
Citation: J. Bondestam et al., Major surgery increases serum levels of vascular endothelial growth factoronly temporarily, AM J SURG, 179(1), 2000, pp. 57-59
Authors:
Ruotsalainen, TM
Halme, M
Tamminen, K
Szopinski, JN
Niiranen, A
Pyrhonen, S
Riska, H
Maasilta, P
Jekunen, A
Mantyla, M
Kajanti, M
Joensuu, H
Sarna, S
Cantell, K
Mattson, K
Citation: Tm. Ruotsalainen et al., Concomitant chemotherapy and IFN-alpha for small cell lung cancer: A randomized multicenter phase III study, J INTERF CY, 19(3), 1999, pp. 253-259
Authors:
Salven, P
Orpana, A
Joensuu, H
Citation: P. Salven et al., Leukocytes and platelets of patients with cancer contain high levels of vascular endothelial growth factor, CLIN CANC R, 5(3), 1999, pp. 487-491
Authors:
Monni, O
Franssila, K
Joensuu, H
Knuutila, S
Citation: O. Monni et al., BCL2 overexpression in diffuse large B-cell lymphoma, LEUK LYMPH, 34(1-2), 1999, pp. 45-52
Authors:
Ristamaki, R
Joensuu, H
Jalkanen, S
Citation: R. Ristamaki et al., Serum CD44 in non-Hodgkin's lymphoma, LEUK LYMPH, 33(5-6), 1999, pp. 433-440
Phase II study of vinorelbine and gemcitabine for inoperable stage IIIB-IVnon-small-cell lung cancer
Authors:
Isokangas, OP
Knuuttila, A
Halme, M
Mantyla, M
Lindstrom, I
Nikkanen, V
Viren, M
Joensuu, H
Mattson, K
Citation: Op. Isokangas et al., Phase II study of vinorelbine and gemcitabine for inoperable stage IIIB-IVnon-small-cell lung cancer, ANN ONCOL, 10(9), 1999, pp. 1059-1063
Authors:
Joensuu, H
Tenhunen, M
Citation: H. Joensuu et M. Tenhunen, Physical and biological targeting of radiotherapy, ACTA ONCOL, 38, 1999, pp. 75-83
Authors:
Helinto, M
Blomqvist, C
Heikkila, P
Joensuu, H
Citation: M. Helinto et al., Post-mastectomy radiotherapy in pT3N0M0 breast cancer: is it needed?, RADIOTH ONC, 52(3), 1999, pp. 213-217
Authors:
Salven, P
Perhoniemi, V
Tykka, H
Maenpaa, H
Joensuu, H
Citation: P. Salven et al., Serum VEGF levels in women with a benign breast tumor or breast cancer, BREAST CANC, 53(2), 1999, pp. 161-166
Authors:
Lundin, M
Lundin, J
Burke, HB
Toikkanen, S
Pylkkanen, L
Joensuu, H
Citation: M. Lundin et al., Artificial neural networks applied to survival prediction in breast cancer, ONCOL-BASEL, 57(4), 1999, pp. 281-286
Authors:
Hietanen, P
Teerenhovi, L
Joensuu, H
Citation: P. Hietanen et al., Intensified adjuvant cyclophosphamide, methotrexate and 5-fluorouracil therapy: A dose-finding study for ambulatory patients with breast cancer, ONCOL-BASEL, 56(2), 1999, pp. 103-109
Authors:
Villikka, K
Kivisto, KT
Maenpaa, H
Joensuu, H
Neuvonen, PJ
Citation: K. Villikka et al., Cytochrome P450-inducing antiepileptics increase the clearance of vincristine in patients with brain tumors, CLIN PHARM, 66(6), 1999, pp. 589-593
Authors:
Joensuu, H
Pylkkanen, L
Toikkanen, S
Citation: H. Joensuu et al., Late mortality from pT1NOMO breast carcinoma, CANCER, 85(10), 1999, pp. 2183-2189
Authors:
Monni, O
Zhu, Y
Franssila, K
Oinonen, R
Hoglund, P
Elonen, E
Joensuu, H
Knuutila, S
Citation: O. Monni et al., Molecular characterization of deletion at 11q22.1-23.3 in mantle cell lymphoma, BR J HAEM, 104(4), 1999, pp. 665-671
Authors:
Poikonen, P
Saarto, T
Lundin, J
Joensuu, H
Blomqvist, C
Citation: P. Poikonen et al., Leucocyte nadir as a marker for chemotherapy efficacy in node-positive breast cancer treated with adjuvant CMF, BR J CANC, 80(11), 1999, pp. 1763-1766
Authors:
Anttonen, A
Kajanti, M
Heikkila, P
Jalkanen, M
Joensuu, H
Citation: A. Anttonen et al., Syndecan-1 expression has prognostic significance in head and neck carcinoma, BR J CANC, 79(3-4), 1999, pp. 558-564
Authors:
Salven, P
Teerenhovi, L
Joensuu, H
Citation: P. Salven et al., A high pretreatment serum basic fibroblast growth factor concentration is an independent predictor of poor prognosis in non-Hodgkin's lymphoma, BLOOD, 94(10), 1999, pp. 3334-3339
Authors:
Valtola, R
Salven, P
Heikkila, P
Taipale, J
Joensuu, H
Rehn, M
Pihlajaniemi, T
Weich, H
deWaal, R
Alitalo, K
Citation: R. Valtola et al., VEGFR-3 and its ligand VEGF-C are associated with angiogenesis in breast cancer, AM J PATH, 154(5), 1999, pp. 1381-1390
Authors:
Hemmer, S
Wasenius, VM
Knuutila, S
Franssila, K
Joensuu, H
Citation: S. Hemmer et al., DNA copy number changes in thyroid carcinoma, AM J PATH, 154(5), 1999, pp. 1539-1547
Authors:
Joensuu, H
Holli, K
Heikkinen, M
Suonio, E
Aro, AR
Hietanen, P
Huovinen, R
Citation: H. Joensuu et al., Combination chemotherapy versus single-agent therapy as first- and second-line treatment in metastatic breast cancer: A prospective randomized trial, J CL ONCOL, 16(12), 1998, pp. 3720-3730